EFFECTS OF HIGH-DOSE KETOCONAZOLE ON PATIENTS WHO HAVE ANDROGEN-INDEPENDENT PROSTATIC-CANCER

被引：0
|
作者：
EICHENBERGER, T
TRACHTENBERG, J
机构：
[1] TORONTO GEN HOSP,DEPT SURG,DIV UROL,EN-14-209,200 ELIZABETH ST,TORONTO M5G 2C4,ONTARIO,CANADA
[2] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
CANADIAN JOURNAL OF SURGERY | 1989年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：349 / 352
页数：4
相关论文
共 50 条
  • [21] A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer
    Hamilton, M
    Dahut, W
    Brawley, O
    Davis, P
    Wells-Jones, T
    Kohler, D
    Duray, P
    Liewehr, DJ
    Lakhani, N
    Steinberg, SM
    Figg, WD
    Reed, E
    ACTA ONCOLOGICA, 2003, 42 (03) : 195 - 201
  • [22] COMBINED KETOCONAZOLE AND LHRH PRODUCING OBJECTIVE RESPONSES IN PATIENTS WITH PROSTATIC-CANCER WHO HAVE FAILED CONVENTIONAL TREATMENT
    KERLE, D
    WARE, H
    SMITH, CB
    YEO, T
    ALLEN, J
    BLOOM, SR
    WILLIAMS, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1395 - 1395
  • [23] ANDROGEN INVOLVEMENT IN THE DEVELOPMENT OF ANDROGEN INDEPENDENT PROSTATIC-CANCER CELLS
    KYPRIANOU, N
    ISAACS, JT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 240 - 240
  • [24] DERIVATION OF ANDROGEN-INDEPENDENT HUMAN LNCAP PROSTATIC-CANCER CELL SUBLINES - ROLE OF BONE STROMAL CELLS
    WU, HC
    HSIEH, JT
    GLEAVE, ME
    BROWN, NM
    PATHAK, S
    CHUNG, LWK
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) : 406 - 412
  • [25] A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer
    Chan, Joseph S.
    Beer, Tomasz M.
    Quinn, David I.
    Pinski, Jacek K.
    Garzotto, Mark
    Sokoloff, Mitchell
    Dehaze, Daniel R.
    Ryan, Christopher W.
    BJU INTERNATIONAL, 2008, 102 (11) : 1601 - 1606
  • [26] KETOCONAZOLE LOWERS SERUM ANDROGENS IN PATIENTS WITH PROSTATIC-CANCER
    TRACHTENBERG, J
    CLINICAL RESEARCH, 1983, 31 (03): : A696 - A696
  • [27] Response to ketoconazole after failure of docetaxel in patients with advanced androgen-independent prostate cancer (AIPC).
    Jean, G. W.
    Shah, S.
    Keisner, S. V.
    GressettUssery, S. M.
    Dowell, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] INHIBITION OF GROWTH AND INCREASE OF ACID-PHOSPHATASE BY TESTOSTERONE ON ANDROGEN-INDEPENDENT MURINE PROSTATIC-CANCER CELLS TRANSFECTED WITH ANDROGEN RECEPTOR CDNA
    SUZUKI, H
    NIHEI, N
    SATO, N
    ICHIKAWA, T
    MIZOKAMI, A
    SHIMAZAKI, J
    PROSTATE, 1994, 25 (06): : 310 - 319
  • [29] Oral low-dose dexamethasone for androgen-independent prostate cancer patients
    Komiya, Akira
    Shimbo, Masaki
    Suzuki, Hiroyoshi
    Imamoto, Takashi
    Kato, Tomonori
    Fukasawa, Satoshi
    Kamiya, Naoto
    Naya, Yukio
    Mori, Ikuo
    Ichikawa, Tomohiko
    ONCOLOGY LETTERS, 2010, 1 (01) : 73 - 79
  • [30] High-dose calcitriol, docetaxel, and estramustine in androgen-independent prostate cancer (AIPC): A phase I/II study.
    Tiffany, NM
    Ryan, CW
    Garzotto, M
    Wersinger, EM
    Beer, TM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 426S - 426S
12345